Benefits, limitations, and controversies on patient-based real-time quality control (PBRTQC) and the evidence behind the practice.

van Rossum, Huub H; Bietenbeck, Andreas; Cervinski, Mark A; Katayev, Alex; Loh, Tze Ping; Badrick, Tony C

van Rossum, Huub H; Bietenbeck, Andreas; Cervinski, Mark A; Katayev, Alex; Loh, Tze Ping; Badrick, Tony C.

Afiliação

van Rossum HH; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bietenbeck A; Huvaros, The Netherlands.
Cervinski MA; Institut für Klinische Chemie und Pathobiochemie Klinikum, Munich, Germany.
Katayev A; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Loh TP; The Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Badrick TC; Laboratory Corporation of America Holdings, Elon, NC, USA.

Clin Chem Lab Med ; 2021 Mar 10.

Article em En | MEDLINE | ID: mdl-33691350

Palavras-chave

average of normals; moving average; patient-based real-time quality control (PBRTQC); quality assurance; quality control

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article